Solugen Stock for Accredited Investors

Climate Tech
By UpMarket Research  |  Last updated: July 2026
CEO Gaurab Chakrabarti Founded 2016 HQ Houston, US

Solugen is a Houston-based chemical manufacturing company that uses enzyme engineering, metal catalysis, and software optimization to make low-carbon chemicals from renewable feedstocks. It sells industrial ingredients as drop-in replacements and custom co-developed products for sectors like water treatment, agriculture, and aerospace.

Access to pre-IPO shares is available to accredited investors through UpMarket.

Latest Price
$2.0B
Debt Financing, Jun 2024, Perplexity
UpMarket Estimate
$2.0B
Based on UpMarket valuation model
Previous Price
$2.0B
Debt Financing Jun 2024

How to Invest in Solugen Through UpMarket

Solugen shares are not on public exchanges. UpMarket provides accredited investors access through secondary market transactions.

Step 01

Verify accredited investor status

Confirm eligibility under SEC Rule 501 of Regulation D. Income or net worth threshold applies.

Step 02

Create an UpMarket account

Complete KYC/AML onboarding. Typically 1–2 business days. Licensed rep assigned on signup.

Step 03

Review available Solugen offerings

Full offering memoranda and risk disclosures provided before any commitment is required.

Step 04

Complete subscription documents

Review and sign subscription agreement. All documents handled digitally through the platform.

Step 05

Fund your investment

Wire transfer or ACH. $50K minimum. Funds held in custodial account until close.

Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.

$1.3B+
UpMarket has brokered over $1.3 billion in alternative investments*
*Includes principal invested and appreciation of investments originated via the UpMarket platform based on historical trade volume and valuation estimates through March 31, 2026. Of the total, approximately $301 million is managed by UpMarket Management, with the remaining originated investments managed by affiliates. Past performance is not predictive of future results.

Valuation Growth Over Time

Post-money valuation by round
Previous rounds Most recent
DateRoundPPS (split-adj.)Valuation
Jun 2024 Debt Financing $2.0B
Jun 2024 Debt Financing $2.0B
Apr 2019 Series B $250M
May 2018 Series A
2016 Seed

Solugen Revenue and Growth

Annual revenue

Why Investors Are Watching Solugen

Growth Signal

Solugen raised over $850M and now operates multiple sites

As of March 2025, Solugen had raised over $850 million in equity and debt financing, including a $213.6 million DOE loan guarantee in June 2024. The company said it operates multiple sites and serves customers across oil & gas, aerospace & defense, agriculture, water treatment, construction, personal care, and cleaning.

Competitive Moat

Enzyme-catalyst platform targets lower-emission chemistry

Solugen combines enzyme engineering, metal catalysis, and software optimization to make high-performance chemicals from renewable feedstocks at industrial scale. The company says the process can deliver lower emissions, higher yields, and improved unit economics versus conventional petrochemical methods.

Market Opportunity

Aiming to replace legacy petrochemicals across many sectors

Solugen’s mission is to “de-fossilize the chemicals industry” by replacing traditional petrochemical processes with enzyme- and metal-catalyst-based alternatives. If successful, the platform could become a fossil-free substitute for legacy chemical infrastructure across energy and AI-linked industrial supply chains.

Interested in Solugen stock? Fill out the form above or sign up directly. Subject to availability. Accredited investors only.

Request access →

Solugen Leadership Team

Gaurab Chakrabarti
CEO
Sean Hunt
CTO

UpMarket Investment Curation Process

  • Full diligence on every offering

    UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.

  • Strategy, fees & legal reviewed in full

    We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers — legal counsel, auditor, administrator, and custodian.

  • Disciplined managers only

    We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.

  • Built around your objectives

    Our goal is to empower you to build a portfolio that best meets your individual investment objectives.

Ready to access institutional-grade private market investments? Unlock private markets

Solugen Stock FAQ

No. As of March 2026, Solugen is a private company and does not trade on any public stock exchange. Accredited investors can access Solugen shares through UpMarket, a FINRA-registered broker-dealer that specializes in pre-IPO investments.

Solugen does not have a public stock price because it is privately held. The most recent known share price comes from its last funding round. Pre-IPO share prices on the secondary market may differ from the last round price depending on supply, demand, and market conditions.

Yes. Accredited investors can indicate interest in Solugen shares through UpMarket by filling out the form on this page or creating an account at upmarket.co. All pre-IPO offerings are subject to availability and require a $50,000 minimum investment. UpMarket is a FINRA-registered broker-dealer and has brokered more than $500M in alternative investments since 2019.

Pre-IPO investments carry significant risks. Solugen shares are illiquid, meaning there is no public market to sell them quickly. There is no guaranteed exit timeline or return. The investment is speculative in nature, and investors should be prepared for the possibility of total loss. Valuations of private companies can fluctuate substantially between funding rounds. Investors should consult their financial advisor and review all offering documents before investing.

In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.

There are two primary exit paths for pre-IPO holdings: selling your shares on the secondary market to another buyer, or holding until the company completes an IPO or is acquired. Both paths are subject to transfer restrictions, company approval (right of first refusal), and market conditions. The timing of any exit is unpredictable, and investors should plan for a multi-year holding period.

The minimum investment for most pre-IPO offerings on UpMarket is $50,000. This amount may vary depending on the specific offering and share availability. There are no fees to create an UpMarket account or browse available investments. Investors only pay transaction-related fees when they complete an investment.

UpMarket's valuation estimate of is derived from a proprietary model that incorporates multiple data sources: funding round data (Caplight), revenue estimates (Sacra), secondary market pricing, and public company comparables. The model applies a private company discount to the public comp multiple to account for illiquidity and information asymmetry. This estimate is not investment advice and may differ substantially from the price at which shares actually trade.

Solugen uses enzyme engineering, metal catalysis, and software optimization to produce low-carbon chemicals from renewable feeds, generating $44.7M in 2024 revenue; it has raised over $850M and operates multiple sites — accredited investors can access Solugen stock through UpMarket.

Invest in Solugen Request access